1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats-Reference-Cited by-同舟云学术

1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats

Published:2002-09 Issue:1 Volume:330 Page:49-52
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Luchowski Piotr,Luchowska Elzbieta,Turski Waldemar A.,Urbanska Ewa M.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference22 articles.

1. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?;Beal;Ann. Neurol.,1992

2. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid;Beal;J. Neurosci.,1993

3. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Burns;Proc. Natl. Acad. Sci. USA,1983

4. Astrocytes as the site for bioactivation of neurotoxins;Di Monte;Neurotoxicology,1996

5. Characterization of rat brain kynurenine aminotransferases I and II;Guidetti;J. Neurosci. Res.,1997

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Memantine and the Kynurenine Pathway in the Brain: Selective Targeting of Kynurenic Acid in the Rat Cerebral Cortex;Cells;2024-08-26

2. Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson’s Disease—A Narrative Review;International Journal of Molecular Sciences;2024-03-02

3. Kynurenic Acid Acts as a Signaling Molecule Regulating Energy Expenditure and Is Closely Associated With Metabolic Diseases;Frontiers in Endocrinology;2022-02-24

4. Endogenous Kynurenic Acid and Neurotoxicity;Handbook of Neurotoxicity;2022

5. Kynurenic acid in neurodegenerative disorders—unique neuroprotection or double‐edged sword?;CNS Neuroscience & Therapeutics;2021-12-03